Practical measurement of affordability: an application to medicines
LM Niëns, E Van de Poel, A Cameron, M Ewen, R Laing & WBF Brouwer
Volume 90, Number 3, March 2012, 219-227
Table 3. Pecentage of population impoverished by or at risk of incurring catastrophic expenditure by purchasing treatment with lowest-priced generic equivalent of glibenclamide, by macro method using macro data for India and Indonesia
| Country (year) | Population (%) below PL before medicine purchase (Ipre) |
Population (%) impoverished by medicine purchase (Ipost − Ipre)a |
Catastrophic expenditure (Xcat)b | |||
|---|---|---|---|---|---|---|
| < US$ 1.25c PL | < US$ 2.00c PL | < US$ 1.25c PL | < US$ 2.00c PL | |||
| Indonesia (2005) | 0.0 | 9.8 | 0.0 | 1.6 | 11.6 | |
| India (2000) | 22.2 | 54.1 | 4.8 | 2.8 | 51.8 | |
Ipost, percentage of the population below the poverty line (PL) after expenditure; Ipre, percentage of the population below the PL before expenditure; Xcat, percentage of the population at risk of incurring a catastrophic expenditure at a threshold of 5% of per capita household expenditures
a Impoverishment method.
b Catastrophic expenditure method.
c Purchasing power parity United States dollars (2005).